OptionsHouse

Options Trading News

December 5, 2012  Wed 9:59 AM CT

ACAD: SEE CHART GET CHAIN FIND STRATEGIES
Acadia Pharmaceuticals has slipped back below a key $5 level, but today's option activity is topped by large call trade.

optionMONSTER's systems show that a trader sold 7,500 December 2.50 calls against open interest of more than 18,000. At the same time, he or she bought 7,500 January 2014 4 calls for the ask price of $1.95 in volume that dwarfs open interest of just 3 contracts, so this is new activity.

If the December calls were sold to open a new position, this is a diagonal call spread. But it seems much more likely that this is a roll, with the trader selling the in-the-money calls that will expire in a few weeks and opening the position out more than a year to take advantage of any further gains.

ACAD is down 4 percent to $4.80 this morning. The stock gapped up last week from just above $2 to a high of $6.54 on positive news about an antipsychotic drug that it is developing. Shares slipped but have still been closing at or above $5 since then.

More than 20,000 ACAD options have already changed hands this morning, more than twice its daily average over the last month.
Share this article with your friends


Related Stories

ACAD

Limited upside seen for Acadia Pharma

June 17, 2016

The biopharmaceutical company has seen its share price double in recent months, but one trader is betting that further gains will be limited.

OptionsHouse

TRADING WEEKLY OPTIONS

The fastest money in the market
View full report »

Premium Services

Education & Strategy

Know the risks behind covered calls

Selling calls is a popular strategy for both retail and institutional traders, but they typically do it in very different fashions.

View more education articles »